Aastrom Biosciences and Zellera AG Announce the Initiation of a Clinical Trial for Bone Grafting in Spain
Aastrom's Proprietary TRCs to be Utilized in Second European Clinical Study to Treat Major Bone Fractures
31-Mar-2004 -
Ann Arbor, Michigan. Aastrom Biosciences, Inc. and its wholly owned subsidiary, Zellera AG, announced the initiation of a bone grafting clinical trial to be conducted by ITRT (Institut de Terapia Regenerativa Tisular) at Hospital General de l'Hospitalet, Hospital de Barcelona and Centro Medico ...
chronic pain
clinical trials
Germany
+2